Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tranexamic acid versus azelaic acid for acne-related post-inflammatory hyperpigmentation
IRCT20120215009014N356Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Post-inflammatory hyperpigmentation (PIH) and acne vulgaris comparing Topical tranexamic acid 5% with Azelaic acid 20% (2 arms). Primary endpoint: Improvement of hyperpigmentation due to acne. Started Jun 2020; status: completed.
02
Drugs
tranexamic acidAzelaic acid
03
Conditions
Post-inflammatory hyperpigmentation (PIH)acne vulgaris
Beyond the preview
Go deeper on IRCT20120215009014N356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N356.